Healio
March 25, 2017
Improvements in biomarkers and genetic tests have refined screening methods to reduce unnecessary biopsies and overdetection of indolent disease. The underlying argument from prostate cancer screening critics is that the method in which serum PSA is used causes more harm than good. It is with this context that I will build my argument that the proponents of prostate cancer screening have risen to the challenge during the past decade.